ProQR Therapeutics N.V. buy Oppenheimer Holdings Inc.
Start price
10.01.25
/
50%
€2.36
Target price
10.01.26
€14.62
Performance (%)
-37.64%
End price
11.01.26
€1.47
Summary
This prediction ended on 11.01.26 with a price of €1.47. Massive losses of -37.64% were the result for the BUY prediction by Oppenheimer_Holdings. Oppenheimer_Holdings has a follow-up prediction for ProQR Therapeutics N.V. where he still thinks ProQR Therapeutics N.V. is a Buy. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | 0.215% | 0.215% | -34.898% |
| iShares Core DAX® | -1.933% | 2.239% | 16.921% |
| iShares Nasdaq 100 | -0.972% | 0.226% | 5.003% |
| iShares Nikkei 225® | -2.056% | 5.685% | 19.218% |
| iShares S&P 500 | -1.185% | 0.867% | 2.378% |
Comments by Oppenheimer_Holdings for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $15.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten
Current prediction by Oppenheimer_Holdings for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.38
13.05.25
13.05.25
€8.10
13.05.26
13.05.26
5.72%
07:45
07:45
